Ultragenyx Pharma Appoints Howard Horn as CFO
Portfolio Pulse from Benzinga Newsdesk
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) has announced the appointment of Howard Horn as its new executive vice president and chief financial officer (CFO), effective from October 16, 2023. Horn will be responsible for leading the finance, accounting, corporate strategy, and investor relations functions.
July 12, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
The appointment of Howard Horn as CFO of Ultragenyx Pharmaceutical Inc. could bring new strategic directions to the company's finance and corporate strategy. This could potentially impact the company's stock in the short term.
The appointment of a new CFO often brings new strategic directions and policies, which could potentially impact the company's financial performance and hence its stock price. However, the exact impact would depend on the market's perception of the new CFO and his strategies.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100